http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103520122-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95474db7a0f95d96758dad5ed9b50036
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
filingDate 2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_127a6d6dd59987418ed1d587f955b77a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34330d4a09c735aa2046aa34dc9b233b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be121530219dea02b0822fe42e955625
publicationDate 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103520122-B
titleOfInvention Preparation method for Bumetanide freeze-dried powder preparation for injection
abstract The invention provides a bumetanide freeze-dried powder preparation for injection and a preparation method thereof. The method consists of: weighing 10ml of glycerol and water for injection in a volume ratio of 1:4-2:3, and stirring them to obtain a latent solvent; weighing 0.5g of bumetanide and dissolving it in the latent solvent, conducting filtering to clarity, thus obtaining a solution A; weighing 200g of mannitol, adding water for injection accounting for 80% of the total amount, carrying out stirring and filtering to clarity, thus obtaining a solution B; mixing the solution A and the solution B evenly, then adding the remaining water for injection to a total amount of 2000ml, performing degerming filtering, then subjecting the product to filling into 1000 10ml tube-type bottles respectively according to a dosage of 2.0ml/bottle; subjecting the tube-type bottles to heat preservation for 4h under -45DEG C; conducting vacuum pumping to a vacuum degree of not greater than 20pa, raising the slab temperature to -5DEG C at a rate of 2DEG C/h, and carrying out heat preservation for 18h; raising the slab temperature to 30DEG C at a rate of 7DEG C/h, and carrying out heat preservation for 2h, thus obtaining the bumetanide freeze-dried powder preparation for injection. According to the invention, the product stability is effectively ensured, the content of impurities is reduced, and the re-dissolubility of the product is good.
priorityDate 2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42672
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ83906
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP87563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62551
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ84177
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5TJ03
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11825
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03252
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96629
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO40958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114548
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19151
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO71150
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8JN66
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68986
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO71070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24221
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07885
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3454
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9WF19
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10381
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396101
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11998
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19119
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68984
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9QM72
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533897
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352922
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2471
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9IIH4

Total number of triples: 66.